BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients
Published inBreast Cancer Research and Treatment, vol. 174, no. 3, p. 775-783
Publication date2019
Abstract
Citation (ISO format)
FRIEDLAENDER, Alex et al. BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients. In: Breast Cancer Research and Treatment, 2019, vol. 174, n° 3, p. 775–783. doi: 10.1007/s10549-018-05127-2
Main files (1)
Article (Published version)

Identifiers
- PID : unige:120074
- DOI : 10.1007/s10549-018-05127-2
- PMID : 30635808
ISSN of the journal0167-6806